Varicella vaccination safety in children with allergy;Bezpieczeństwo stosowania szczepień przeciwko ospie wietrznej u dzieci z chorobami alergicznymi

Pediatria Polska

Volumn 79, Issue 1, 2004, Pages 27-31

  Bednarek, Małgorzata ^a   Majda Stanisławska, Ewa ^a  

^a UM   (Poland)

Author keywords

Allergy; Prevention; Varicella

Indexed keywords

CHICKENPOX VACCINE; OKAVAX; VARICELLA ZOSTER VACCINE;

ALLERGY; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; SIDE EFFECT; VACCINATION;

EID: 1342268808     PISSN: 00313939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Seward J.F.: Update on varicella, Pediatr. Infect. Dis. J. 2001, 619-621.
2. Gershon A. i in.: Varicella vaccine: the American experience, J. Infect. Dis. 1992, 166 (Suppl. 1), 63-68.
3. American Academy of Pediatrics. Varicella-Zoster infections. [w:] 2000 Red Book 2000. Report of the Committee on Infectious Diseases, L.K. Pickering, 25th ed. Elk Grove Village, IL; American Academy of Pediatrics 2000, 624-638.
4. Baba K. i in.: Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood, J. Pediatr. 1982, 100, 881-885.
5. Broyer M., Boudaillez B.: Varicella vaccine in children with chronic renal insufficiency, Postgrad. Med. J., 1985, 61(Suppl 4), 103-106.
6. Anon. Epidemiological surveillance of varicella-zoster virus infection in Singapore, Epidemiol News Bull. 1996, 22, 61-64.
7. Lieu T.A. i in.: Cost-effectiveness of routine varicella vaccination program for US children, JAMA 1994, 271, 375-381.
8. Takahashi M.: Clinical overview of varicella vaccine: development and early studies, Pediatrics 1986, 78 (suppl) 736-741.
9. Moffat J.F. i in.: Attenuation of the vaccine Oka strain of varicella-zoster virus and the role of glycoprotein C in Alpha herpes virus virulence demostrated in SCID-hu mouse, J. Virol. 1998, 72, 965-974.
10. Takahashi M.: Development of a live varicella vaccine - past and future, Jpn. J. Infect. Dis. 2000, 52, 47-55.
11. Anon. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995, 95, 791-796.
12. Advisory Committee on Immunization Practices. Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality weekly Report, 1996, 48, 1-5.
13. Advisory Committee on Immunization Practices. Prevention of varicella. Update Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality weekly Report, 1999, 45, 1-36.
14. Asano Y. i in.: Experience and reason: twenty year follow-up of protective immunity of the Oka strain live varicella vaccine, Pediatrics 1994, 94, 524-526.
15. Starr S.E.: Varicella in children receiving steroids for asthma: risks and management, Ped. Inf. Dis. J. 1992, 11, 419-420.
16. Siegrist C.A.: Vaccination strategies for children with specific medical conditions: a paediatrician's viewpoint, Eur. J. Pediatr. 1997, 156, 899-904.
17. Heath R.B., Malpas J.S.: Experience with the live Oka-strain varicella vaccine in children with solid tumors. Postgrad. Med J. 1985, 61 (Suppl 4), 107-111.